Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call

Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call

Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR T therapy in metastatic colorectal cancer

Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR T therapy in metastatic colorectal cancer

Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors

Celyad Presents Update on Autologous & Allogeneic NKG2D-based CAR-T Therapies in Solid Tumors

Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress

Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress

Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program

Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

Updated results from Phase I trials assessing a NKG2D CAR T-cell approach in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome patients

Updated results from Phase I trials assessing a NKG2D CAR T-cell approach in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome patients

Development of a next generation allogeneic CAR-T cell platform without gene editing

Development of a next generation allogeneic CAR-T cell platform without gene editing

Modeling NKG2D-based CAR-T cell therapy in animals with acute myeloid leukemia

Modeling NKG2D-based CAR-T cell therapy in animals with acute myeloid leukemia

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights